CAS 86879-39-2: 3-Carboxy-4-methyl-5-propyl-2-furanpropanoic acid

CMPF is a microtubule protein inhibitor that can be used to study tumors.

Applications CMPF-d3 is the labeled analogue of CMPF (C595000). CMPF is a drug-binding inhibitor which is also a constituent of urine. CMPF can inhibit specific T4 binding in serum by increasing the free concentration of direct competitors. References Mabuchi, H., Nakahashi, H.: Nephron, 44, 277 (1986); Lim, C.F., et. al.: Metabolism Clin. Exp., 42, 1468 (1993);

CMPF

3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid is an analytical method to measure the concentration of fatty acids in biological samples. It can be used to diagnose and monitor various diseases, such as hepatic steatosis and diabetes. 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid is measured by multivariate logistic regression, a statistical technique that measures the likelihood of a dependent variable (e.g., disease activity) based on one or more independent variables (e.g., maternal blood). 3CMPFAPA is quantified using an injection solution for liquid chromatography (LC). This compound can be analyzed in human serum, which is another biological sample that can be used for diagnosis.

Applications CMPF is a drug-binding inhibitor which is also a constituent of urine. CMPF can inhibit specific T4 binding in serum by increasing the free concentration of direct competitors. References Mabuchi, H., Nakahashi, H.: Nephron, 44, 277 (1986); Lim, C.F., et. al.: Metabolism Clin. Exp., 42, 1468 (1993);